key: cord-0262463-ixf9gzj9
authors: Diray-Arce, Joann; Miller, Helen E.R.; Henrich, Evan; Gerritsen, Bram; Mulè, Matthew P.; Fourati, Slim; Gygi, Jeremy; Hagan, Thomas; Tomalin, Lewis; Rychkov, Dmitry; Kazmin, Dmitri; Chawla, Daniel G.; Meng, Hailong; Dunn, Patrick; Campbell, John; Sarwal, Minnie; Tsang, John S.; Levy, Ofer; Pulendran, Bali; Sekaly, Rafick; Floratos, Aris; Gottardo, Raphael; Kleinstein, Steven H.; Suárez-Fariñas, Mayte
title: The Immune Signatures Data Resource: A compendium of systems vaccinology datasets
date: 2021-11-08
journal: bioRxiv
DOI: 10.1101/2021.11.05.465336
sha: c15dd34cd1dbdca3ae02a796dee56e4c22639a7b
doc_id: 262463
cord_uid: ixf9gzj9

Vaccines are among the most cost-effective public health interventions for preventing infection-induced morbidity and mortality, yet much remains to be learned regarding the mechanisms by which vaccines protect. Systems immunology combines traditional immunology with modern ‘omic profiling techniques and computational modeling to promote rapid and transformative advances in vaccinology and vaccine discovery. The NIH/NIAID Human Immunology Project Consortium (HIPC) has leveraged systems immunology approaches to identify molecular signatures associated with the immunogenicity of many vaccines, including those targeting seasonal influenza, yellow fever, and hepatitis B. These data are made available to the broader scientific community through the ImmuneSpace data portal and analysis engine leveraging the NIH/NIAID ImmPort repository1,2. However, a barrier to progress in this area is that comparative analyses have been limited by the distributed nature of some data, potential batch effects across studies, and the absence of multiple relevant studies from non-HIPC groups in ImmPort. To support comparative analyses across different vaccines, we have created the Immune Signatures Data Resource, a compendium of standardized systems vaccinology datasets. This data resource is available through ImmuneSpace, along with code to reproduce the processing and batch normalization starting from the underlying study data in ImmPort and the Gene Expression Omnibus (GEO). The current release comprises 1405 participants from 53 cohorts profiling the response to 24 different vaccines and includes transcriptional profiles and antibody response measurements. This novel systems vaccinology data release represents a valuable resource for comparative and meta-analyses that will accelerate our understanding of mechanisms underlying vaccine responses.

Vaccines are among the most cost-effective public health interventions for preventing infection-induced 48 morbidity and mortality, yet much remains to be learned regarding the mechanisms by which vaccines 49 protect. Systems immunology combines traditional immunology with modern 'omic profiling techniques 50 and computational modeling to promote rapid and transformative advances in vaccinology and vaccine 51 discovery. The NIH/NIAID Human Immunology Project Consortium (HIPC) has leveraged systems 52 immunology approaches to identify molecular signatures associated with the immunogenicity of many 53 vaccines, including those targeting seasonal influenza, yellow fever, and hepatitis B. These data are made 54 available to the broader scientific community through the ImmuneSpace data portal and analysis engine 55 leveraging the NIH/NIAID ImmPort repository 1,2 . However, a barrier to progress in this area is that reproducible results, we also archived a static copy of the data as a "virtual study" in ImmuneSpace 137 ( Figure 1A & 2). 

Transcriptomic profiles of participants without reported ages were compared to the reference dataset via a 225 correlation profile, providing age estimates for the sample. Finally, random subsets of genes from the 226 subject's transcriptomic profile were bootstrapped to ascertain a confidence interval for the imputed age.

We generated the reference dataset using the transcriptomic profiles of 21 studies in our resource for 228 which age was reported. The studies were split into younger (age < 50) and older (age ≥ 50) cohorts, thus 229 two different models were generated, and only baseline transcriptomic profiles were used in the reference 230 dataset. As RAPToR also enables phenotypic data to be incorporated into the interpolation model, each 

We evaluated the main sources of variation on the gene expression matrix to identify and adjust technical 294 confounders (RNA-seq, Affymetrix arrays, Illumina arrays, etc.), study, and specimen types (e.g., whole 295 blood vs. PBMCs) using the baseline samples. Since all studies enrolled healthy volunteers, and the first 296 sample was taken pre-vaccination, pathogen and vaccine type would not affect the baseline data. Figure   297 3B clearly demonstrates robust clustering of samples by study, which are also grouped by platform type.

The study effect and type of platform used accounted for the vast majority (95%) of variation, followed 299 by specimen types (3.6%). It is thus essential that the data are corrected for these major effects prior to 300 any analytical usage [see Materials and Methods for further details]. The study, platform type, and 301 specimen type-specific effects were estimated using a linear model that also included age and Y-302 chromosome presence as additive effects using only baseline expression. Once the study, platform, and 303 specimen-type effects were estimated, they were eliminated from the entirety of the expression matrix.

304 Figure 3B shows that those effects can successfully be adjusted from the data, thus leading to a matrix of 305 expression that is free of most technical biases induced by the laboratory and cell-type effects.

We report the total number of assay samples collected from the transcriptomic and immune response 308 datasets tallied by targeted pathogen and vaccine type, across multiple systems vaccinology datasets 309 ( Figure 4A ). We captured about ~3000 HAI antibody titer results from influenza studies that were 

Precision weights unlock linear model 474 analysis tools for RNA-seq read counts

Guidelines for human gene nomenclature

Sources of variation in baseline gene expression levels from 479 toxicogenomics study control animals across multiple laboratories

Real age prediction from the transcriptome with RAPToR. 482 bioRxiv

A crowdsourcing approach for reusing and meta-analyzing gene expression data